OBSTETRIC ANESTHESIA: TOCOLYSIS AND HEMORRHAGE
产科麻醉:安胎和出血
基本信息
- 批准号:3467321
- 负责人:
- 金额:$ 9.89万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1989
- 资助国家:美国
- 起止时间:1989-07-01 至 1994-06-30
- 项目状态:已结题
- 来源:
- 关键词:beta adrenergic agent beta adrenergic receptor dosage eicosanoid metabolism embryo /fetus drug adverse effect embryo /fetus pharmacology ephedrine epidural anesthesia hemorrhage indomethacin inhibitor /antagonist magnesium muscle contraction muscle relaxants obstetric anesthesia phenylephrine pregnancy circulation premature labor sheep sulfates tissue /cell culture tocolytic agents
项目摘要
Preterm delivery is the leading cause of perinatal morbidity and
mortality in the United States. Obstetricians often give beta-
sympathomimetic agents (e.g. ritodrine) to treat preterm labor, a therapy
called tocolysis. Although ritodrine is relatively selective for the
beta 2 receptor (e.g., uterine smooth muscle), beta 1-receptor
stimulation also occurs, resulting in increased maternal heart rate and
systemic vasodilation. Magnesium sulfate (MgSO4) is often given as an
alternate tocolytic drug; many clinicians believe that it incurs less
risk of cardiovascular side effects. Obstetrician usually avoid
ritodrine in patients at risk for hemorrhage, for fear of severe
hypotension. Anesthesiologists often avoid regional anesthesia in
patients recently subjected to infusion of either ritodrine or MgSO4.
There are few data regarding interactions between tocolysis, hemorrhage,
and anesthesia. A recent study from this laboratory showed that MgSO4
significantly worsened the maternal hypotensive response to hemorrhage in
gravid ewes. The specific aims of this proposal are: 1) To hemorrhage;
2) To determine whether the tachycardia response to ritodrine alters
maternal and fetal hemodynamic responses to hemorrhage; 3) To study
whether, and if so why, ritodrine increases the risk of hypotension with
epidural anesthesia; and 4) To study whether MgSO4 increases the risk of
hypotension with epidural anesthesia.
Methods. In vitro studies will use the suspended isometric vascular ring
model. The contractile responses of uterine and mesenteric arterial
smooth muscle to various agonists, with and without MgSO4, endothelium,
and indomethacin, will be examined. In vivo studies will use chronically
instrumented gravid ewes. Maternal and fetal arterial catheters will
permit continuous measurement of maternal and fetal systemic arterial
pressures, and intermittent measurement of maternal cardiac output. An
electromagnetic flow probe will allow measurement of uterine blood flow.
A lumbar epidural catheter will facilitate induction of epidural
anesthesia.
The long-term objectives of this proposal are: 1) To elucidate
mechanisms of interaction between tocolytic drugs, hemorrhage, and
anesthesia; and 1) To provide an objective basis for the choice and
management of tocolytic therapy in patients at risk for hemorrhage, as
well as for the choice and management of anesthesia after failed
tocolysis.
早产是围产期发病和死亡的主要原因
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
DAVID H CHESTNUT其他文献
DAVID H CHESTNUT的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('DAVID H CHESTNUT', 18)}}的其他基金
相似海外基金
Angiotensin-(1-7) and beta adrenergic receptor signaling in aging
衰老过程中血管紧张素 (1-7) 和 β 肾上腺素受体信号传导
- 批准号:
10448574 - 财政年份:2022
- 资助金额:
$ 9.89万 - 项目类别:
Angiotensin-(1-7) and beta adrenergic receptor signaling in aging
衰老过程中血管紧张素 (1-7) 和 β 肾上腺素受体信号传导
- 批准号:
10629280 - 财政年份:2022
- 资助金额:
$ 9.89万 - 项目类别:
Novel regulation of beta-adrenergic receptor function by phosphoinositide 3-kinase
磷酸肌醇 3-激酶对 β-肾上腺素能受体功能的新调节
- 批准号:
10591688 - 财政年份:2022
- 资助金额:
$ 9.89万 - 项目类别:
Cardiac Beta-Adrenergic Receptor Density, Evaluated by Cardiac Positron Emission Tomography, in Heart Failure with Atrial Fibrillation
通过心脏正电子发射断层扫描评估心房颤动心力衰竭患者的心脏β-肾上腺素能受体密度
- 批准号:
22K07801 - 财政年份:2022
- 资助金额:
$ 9.89万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Research for predictive indicators of therapeutic response of beta-adrenergic receptor blockers using myocardial tissue of patients with heart failure
利用心力衰竭患者心肌组织研究β-肾上腺素能受体阻滞剂治疗反应的预测指标
- 批准号:
21K16031 - 财政年份:2021
- 资助金额:
$ 9.89万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Beta adrenergic receptor-dependent regulation of leukocytes in acute cardiac injury
急性心脏损伤中白细胞的β肾上腺素受体依赖性调节
- 批准号:
10288087 - 财政年份:2017
- 资助金额:
$ 9.89万 - 项目类别:
Beta adrenergic receptor-dependent regulation of leukocytes in acute cardiac injury
急性心脏损伤中白细胞的β肾上腺素受体依赖性调节
- 批准号:
10063903 - 财政年份:2017
- 资助金额:
$ 9.89万 - 项目类别:
Beta adrenergic receptor resensitization in asthma
哮喘中的β肾上腺素能受体再敏化
- 批准号:
9205534 - 财政年份:2016
- 资助金额:
$ 9.89万 - 项目类别:
Impact of cardiac beta-adrenergic receptor density evaluated by cardiac PET on chronotropic incompetence
心脏 PET 评估心脏 β-肾上腺素能受体密度对变时性功能不全的影响
- 批准号:
15K09966 - 财政年份:2015
- 资助金额:
$ 9.89万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Investigation of the mechanism in the aldosterone regulation through the beta-adrenergic receptor
通过β-肾上腺素受体调节醛固酮的机制研究
- 批准号:
24580463 - 财政年份:2012
- 资助金额:
$ 9.89万 - 项目类别:
Grant-in-Aid for Scientific Research (C)